Disc Medicine, Inc.
IRON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $50 | $46 | $28 | $25 |
| G&A Expenses | $17 | $15 | $12 | $10 |
| SG&A Expenses | $17 | $15 | $12 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $68 | $61 | $40 | $35 |
| Operating Income | -$68 | -$61 | -$40 | -$35 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $5 | $6 | $6 | $5 |
| Pre-Tax Income | -$62 | -$55 | -$34 | -$29 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$62 | -$55 | -$34 | -$29 |
| % Margin | – | – | – | – |
| EPS | -1.77 | -1.58 | -1.02 | -0.98 |
| % Growth | -12% | -54.9% | -4.1% | – |
| EPS Diluted | -1.77 | -1.58 | -1.02 | -0.98 |
| Weighted Avg Shares Out | 35 | 35 | 33 | 30 |
| Weighted Avg Shares Out Dil | 35 | 35 | 33 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $7 | $7 | $6 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$61 | -$54 | -$33 | -$13 |
| % Margin | – | – | – | – |